A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Lean Muscle Development, Hormone-Related Wellness, Digestive Comfort, Dermatologic Health, and Overall Wellness
tiistai 11. elokuuta 2026 päivittänyt: Clean Nutraceuticals
This study will evaluate the effects of Clean Nutra's Shelf Builder Women's Creatine Powder on lean muscle development, hormone-related wellness, digestive comfort, dermatological health, and overall wellness. The study is a single-arm, open-label, virtual trial in which all 35 enrolled participants will use the test product once daily for eight weeks.
Participants will complete self-reported questionnaires at Baseline and at the end of Week 4 and Week 8 to assess changes in lean muscle development, muscular endurance, hormone-related wellness, digestive comfort, hair/nail/skin health, and overall wellness.
Tutkimuksen yleiskatsaus
Tila
Rekrytointi
Ehdot
Interventio / Hoito
Opintotyyppi
Interventio
Ilmoittautuminen (Arvioitu)
35
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskeluyhteys
- Nimi: Patrick Renner
- Sähköposti: hello@citruslabs.com
Opiskelupaikat
-
-
Nevada
-
Las Vegas, Nevada, Yhdysvallat, 89101
- Rekrytointi
- Citruslabs
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
Hyväksyy terveitä vapaaehtoisia
Joo
Kuvaus
Inclusion Criteria:
- Be female.
- Be aged 21-45.
- Engages in structured physical activity ≥3 times per week, with each session lasting at least 30 minutes, (e.g., running, gym/strength training, cycling, team sports, fitness classes).
- Anyone with a menstrual cycle between 24-38 days.
- Anyone who has experienced concerns with at least two of the following, twice per week, over the past four weeks: Hair, skin, and nail health
- Bloating
- Symptoms of hormonal imbalance.
- Anyone with a BMI of 18.5 to 30 kg/m2.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- If taking medications, other supplements, or herbal remedies targeted at lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health, has been consistently taking for at least three months prior to starting the study, and is willing to maintain this routine for the study duration.
- Anyone who is willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
- Resides in the United States.
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and mental health disorders.
- Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.
- Planning on introducing any products or any new forms of prescription medication or supplements that target lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health for the study duration.
- Anyone who has been diagnosed with kidney disease and/or has previously or is currently taking diuretics or kidney medications.
- Anyone who has previously or is currently taking any hormone therapies.
- Anyone who is currently taking medications or supplements that contain zinc or iron.
- Anyone with any allergies or sensitivities to fish, eggs, or any of the study product ingredients.
- Anyone currently consuming products with creatine.
- Anyone diagnosed with a thyroid-related condition.
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- Anyone who has a history of serious illness in the last three months.
- Anyone who has planned surgery during the study period.
- Anyone with a history of substance abuse.
- Anyone who is currently a smoker or has been a smoker in the past 3 months.
- Anyone who has stopped or started using hormonal birth control in the past 2 months.
- Anyone who is vegan and/or does not consume animal products for any reason.
- Anyone currently taking a weight loss medication, including but not limited to Wegovy, Mounjaro, and Ozempic.
- Currently undergoing hair treatment or using other hair growth/thickening products.
- Currently taking any prescription medication for hair loss.
- Anyone with any conditions that affect the hair or scalp (e.g., alopecia areata).
- Anyone who drinks heavily (8 or more alcoholic drinks per week).
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Muut
- Jako: Ei käytössä
- Inventiomalli: Yksittäinen ryhmätehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Shelf Builder Women's Creatine Powder
|
All participants take one scoop (9 g) of Clean Nutra Shelf Builder Women's Creatine Powder mixed in 8 oz of cold water once daily with the first meal of the day for eight weeks.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Lean Muscle Development
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in lean muscle development assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Muscular Endurance
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in muscular endurance assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Digestive Comfort
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in digestive comfort assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Hair
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Nail
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Skin Health
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Symptoms of Hormonal Imbalance
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in symptoms of hormonal imbalance assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Overall Health and Wellness
Aikaikkuna: Baseline, Week 4, and Week 8
|
Self-reported change in overall health and wellness assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Perceived Change in Lean Muscle Strength
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in lean muscle strength assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Exercise Performance
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in exercise performance assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Lean Muscle Development
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in lean muscle development assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Hair
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Nail
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Skin Health
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Mood
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in mood assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Energy Levels
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in energy levels assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Mental Clarity
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in mental clarity assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Digestive Health
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in digestive health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Bloating
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in bloating assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Digestive Comfort
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in digestive comfort assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Muscle Recovery
Aikaikkuna: Baseline, Week 4, and Week 8
|
Participant-perceived change in muscle recovery assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Yhteistyökumppanit
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Tiistai 1. syyskuuta 2026
Ensisijainen valmistuminen (Arvioitu)
Sunnuntai 1. marraskuuta 2026
Opintojen valmistuminen (Arvioitu)
Sunnuntai 1. marraskuuta 2026
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Tiistai 11. elokuuta 2026
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Tiistai 11. elokuuta 2026
Ensimmäinen Lähetetty (Todellinen)
Perjantai 14. elokuuta 2026
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Perjantai 14. elokuuta 2026
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Tiistai 11. elokuuta 2026
Viimeksi vahvistettu
Lauantai 1. elokuuta 2026
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- 20834
- legacy-20834
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Ei
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Ei
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .